Yahoo Finance Bristol-Myers Squibb Earnings, Revenue Beat in Q4
Investing.com - Bristol-Myers Squibb (NYSE:BMY) reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Bristol-Myers Squibb announced earnings per share of $1.22 on revenue of $7.95B. Analysts polled by Investing.com anticipated EPS of $0.89 on revenue of $7.12B. That with comparison to EPS of $0.94 on revenue of $5.97B in the same period a year before. Bristol-Myers Squibb had reported EPS of $1.17 on revenue of $6.01B in the previous quarter. Analysts are expecting EPS of $1.44 and revenue of $10.01B in the upcoming quarter.
Bristol-Myers Squibb shares are up 2.18% from the beginning of the year , still down 4.02% from its 52 week high of $68.34 set on January 22. They are under-performing the S&P Global (NYSE:SPGI) 100 which is up 3.22% year to date.
Bristol-Myers Squibb follows other major Healthcare sector earnings this month
Bristol-Myers Squibb's report follows an earnings beat by J&J on January 22, who reported EPS of $1.88 on revenue of $20.75B, compared to forecasts EPS of $1.87 on revenue of $20.8B.
Merck&Co had beat expectations on Wednesday with fourth quarter EPS of $1.16 on revenue of $11.87B, compared to forecast for EPS of $1.15 on revenue of $11.95B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
Related Articles
Comic: King Elon and Tesla Remain The Biggest Story On Wall Street
Twitter tops expectations with first $1 billion quarterly revenue, but outlook lags
